CSU Symposium at EAACI 2023*
From Past to Present: What’s next for CSU?
Friday, 9 June 2023: 15:45–16:45 CEST
| Agenda | Friday, 9 June 2023 |
| 15:45 pm | Welcome and introductions Dr Clive Grattan |
| 15:50 pm | Exploring the Past: Approaches to CSU Care Dr Clive Grattan |
| 16:05 pm | Current Guidelines in CSU Management Professor Emek Kocatürk Göncü |
| 16:20 pm | What's New in Management: Future of Personalised Medicine Professor Dr. Martin Metz |
| 16:35 pm | Q&A and panel discussion Chaired by Dr Clive Grattan |
| 16:45 pm | Closing statement Dr Clive Grattan |
Have you registered for this symposium focused on improving the patient experience and exploring the development in the management of CSU patients? This live symposium will provide insight into emerging approaches to improve the diagnosis and treatment of chronic spontaneous urticaria (CSU) in the current guidelines. Discover the change in managing CSU patients, identify the advances in classification of CSU, and distinguish the differences in treatment options available for personalised medicine. During the event, you will be able to participate in a Q&A session and listen to a panel discussion in which experts provide insights based on their own clinical experience.
To attend this event live, you must register directly with EAACI. Click here to register now!
Not able to join live? Sign up on the form below to get involved by submitting your questions to the experts, and receive an email when this symposium is published on Medthority to receive your CME credit!*
This symposium aims to explore and broaden your current understanding in several key areas when treating patients with CSU. Through attending this symposium, you will gain 1 CME-CPD point through EACCME®*
After participating in this educational programme, learners will be able to:
- Recognise the advancement in clinical practice for the management of CSU
- Identify the advances in classification of CSU according to current guidelines
- Distinguish the differences in treatment options available for personalised medicine
Dr Clive Grattan
Dr Clive Grattan is a consultant dermatologist at Guy’s and St Thomas’ Hospitals, London, UK.
Disclosures: Dr Clive Grattan is in receipt of honoraria or consultation fees from Novartis, Sanofi, Celltrion, Argenx, and Blueprint
Professor Emek Kocatürk
Emek Kocatürk is Professor at the Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey.
Disclosures: Speaker and advisor for Novartis, Menarini, LaRoche Posey, Sanofi, Bayer
Professor Dr. Martin Metz
Prof. Dr Martin Metz is a Professor of Dermatology at the Institute of Allergology at the Charité – Universitätsmedizin and Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Disclosures: Prof. Dr Martin Metz is in receipt of honoraria or consultation fees from Amgen, AstraZeneca, Argenx, Celidex Therapeutics, Escientpharma, Jasper Therapeutics, Novartis, Pharvaris, Sanofi-Aventis, ThirdHarmonicBio
*This event is accredited under the Hamburg Medical Association and EACCME®.
This content has been developed independently of the sponsor, Novartis Pharma AG, who has had no editorial input into the content. Medthority received education funding from the sponsor in order to provide healthcare professionals registered for the EAACI 2023 Hybrid Congress, and following the congress to Medthority’s healthcare professional members, access to the highest quality medical and scientific information, education and associated relevant content, without any promotional intent.